On November 20, 2019 Medicenna Therapeutics Corp. ("Medicenna" or "the Company") (TSX: MDNA,OTCQB: MDNAF), a clinical stage Immuno-Oncology company, reported that it will host a Key Opinion Leader (KOL) call and webcast for the investment community on Monday, November 25, 2019 at 10:00 AM, ET (Press release, Medicenna Therapeutics, NOV 20, 2019, View Source [SID1234551546]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The KOL call will focus on Medicenna’s MDNA55 recurrent glioblastoma (rGBM) program and the latest Phase 2b clinical study results which will be presented by Dr. John Sampson on Sunday, November 24th, 2019 at the Annual Meeting of the Society of Neuro-Oncology being held from November 20 to 24 at the JW Marriott Desert Ridge Resort in Phoenix, Arizona.
Featured Speaker:
John H. Sampson, MD, PhD, MHSc, MBA Robert H. and Gloria Wilkins Distinguished Professor and Chair of Neurosurgery at Duke University in Durham, NC
Dr. Sampson is an internationally recognized leader in the field of brain cancer immunotherapy, experimental treatment of complex brain tumors and drug delivery to the brain using convection enhanced delivery (CED). He has authored more than 240 peer-reviewed publications documenting the development of multiple immunotherapeutic agents that have affected the standard of care in glioblastoma, the most malignant form of brain cancer. He has remained continuously funded by the National Institutes of Health since 2000. Dr. Sampson earned his medical degree from the University of Manitoba in Winnipeg, Canada and a PhD in neuro- immunology and brain tumor immunotherapy at Duke University. He completed his MBA at the Fuqua School of Business. Dr. Sampson was elected to the prestigious National Academy of Medicine as well as the Association of American Physicians.
Conference call and webcast details:
Date: November 25, 2019
Time: 10:00 am ET
To access the conference audio:
Local dial in: 416-764-8609
North American Toll Free: 1-888-390-0605
Conference ID No.: 38917905
To access the webcast and slide presentation:
Following the event, the archived webcast and Medicenna presentation will be available on the Company’s website at www.medicenna.com.